Last reviewed · How we verify
NCT04846127
CanGaroo® Registry Study
trial testing CanGaroo Envelope in Arrhythmias, Cardiac in 500 participants. Completed in 17 October 2024.
17 April 2023
Quick facts
| Lead sponsor | Elutia Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 25 May 2021 |
| Primary completion | 17 April 2023 |
| Estimated completion | 17 October 2024 |
| Sites | 23 locations across United States |
Drugs / interventions tested
- CanGaroo Envelope
Conditions studied
- Arrhythmias, Cardiac — all drugs for Arrhythmias, Cardiac →
Sponsor
Elutia Inc.
Who can join
18 and older, any sex, with Arrhythmias, Cardiac. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A Multi-Center Registry Evaluating Participants Who Receive CanGaroo Envelope or No Envelope During their CIED Implantation
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04846127
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CanGaroo Envelope
Trials testing the same drug.
- NCT04351269 — Retrospective Experience Of CIED Implantation · completed
Other recruiting trials for Arrhythmias, Cardiac
Currently open trials in the same condition.
- NCT07276139 — PACEVALUE: Development of a Risk Score to Predict Pacing-Induced Cardiomyopathy in Patients Undergoing Pacemaker or ICD · active not recruiting
- NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
- NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT06358391 — To Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Pu · NA · recruiting
Other Elutia Inc. trials
Trials by the same sponsor.
- NCT04645173 — Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation · completed
- NCT04351269 — Retrospective Experience Of CIED Implantation · completed
- NCT04060134 — A Retrospective Breast Reconstruction Study · completed
- NCT03896347 — A Study Evaluating 3-Level OLIF Spine Fusion · withdrawn
- NCT03425682 — ViBone in Cervical and Lumbar Spine Fusion · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04846127 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Elutia Inc.
- Last refreshed: 15 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04846127.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing